get a key
steadybase-$ company MYGN
account_id none on file
legal_name Myriad Genetics Inc
ticker MYGN
cik 899923
domain myriad.com
entry_point_account_id none on file
name Myriad Genetics Inc.
exchange Nasdaq
sector Health Care
hq Salt Lake City, UT, United States
calls 2 filings 0 executives 6 family 0
why_nownone on file
calls
There are some big levers that we're That we've already started to take, including incredibly careful, you know, any additions of headcount really holding steady on that being very deliberate, of course, on the traditional things on any travel entertainment, all those categories.

May 6, 2025 / receipt, needs a key / Sam, CEO | earnings call 2025-05-06 | transcript 4442483b-6176-49c0-b4d9-becc63145925 | chars 38867-39147 | segment 40

So, across commercial, SG&A, and R&D, but I think what you will see is a 25% increase in R&D to support future growth, about an 8% increase in our technology spend, and, you know, belt tightening elsewhere in the organization for an overall pretty modest 3% increase, Scott, I think we're forecasting year over year. So, you know, I think that just reflects our ongoing discipline about operating expense management, dealing with UnitedHealthcare change in a pragmatic way, but reallocating our investment dollars for future growth.

Mar 4, 2025 / receipt, needs a key / Scott, CFO | earnings call 2025-03-04 | transcript 95f6e5d8-82af-4b50-b87c-41a0faaf9bce | chars 26569-27101 | segment 26

filingsnone on file
executives
familynone on file
upcoming
2026-11-02 earnings call scheduled ir
changes
2025-08-18 Senior Vice President, appointed sec_8k
2020-02-06 President, departed sec_8k
mcp_package_hint
steadybase-$